Unique ID issued by UMIN | UMIN000014392 |
---|---|
Receipt number | R000015699 |
Scientific Title | The efficacy and safety of a hypertonic polyethylene glycol - electrolyte lavage solution (PEG-ELS) for patients with constipated patients or regularly user of a laxative: a randomized study |
Date of disclosure of the study information | 2014/06/26 |
Last modified on | 2016/11/10 09:39:31 |
The efficacy and safety of a hypertonic polyethylene glycol - electrolyte lavage solution (PEG-ELS) for patients with constipated patients or regularly user of a laxative: a randomized study
The efficacy and safety of a hypertonic polyethylene glycol - electrolyte lavage solution (PEG-ELS).
The efficacy and safety of a hypertonic polyethylene glycol - electrolyte lavage solution (PEG-ELS) for patients with constipated patients or regularly user of a laxative: a randomized study
The efficacy and safety of a hypertonic polyethylene glycol - electrolyte lavage solution (PEG-ELS).
Japan |
Patients with chronic constipation, functional constipation or regularly use of a laxative
Gastroenterology |
Others
NO
To assess the efficacy and safety of a hypertonic PEG-ELS for patients with constipated patients or regularly user of a laxative compared with a conventional PEG-ELS.
Safety,Efficacy
Not applicable
The rate of poor colon preparation(Ottawa bowel preparation scale>2) and rate of the patients who needed the enema .
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
2
Prevention
Medicine |
A hypertonic PEG-ELS is administrated for colonoscopy bowel preparation.
A conventional PEG-ELS is administrated for colonoscopy bowel preparation.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
(1)Patients with chronic constipation or functional constipation.
(2) 20years or older and up to 80 years old.
(3) Patients judged to resect polyp in total colonoscopy within the past two years, and undergoing polypectomy.
(4) )Written informed consent obtained.
(1) Patients with a history of gastrointestinal tractresection (excluding appendicectomy)
(2) Patients required for colonic ESD
(3) Patients who may have ileus
(4) Patients who have a history of perforation and may have perforation of gastrointestinal tract
(5) Patients with failure of gastric empty
(6) Patients with toxic megacolon
(7) Patients with a history of hypersensitivity to composition of a PEG-ELS or Moviprep
(8) Patients with nausea and vomiting
(9) Patients who request to increase dose of a laxative which is taken commonly from obtaining informed consent to the day before preparation
(10)Patients who may be admitted for purposes of other than polypectomy
(11) Patients who are considered to be unsuitable by the trial investigators
100
1st name | |
Middle name | |
Last name | Mototsugu Kato |
Hokkaido University Hospital
Division of Endoscopy
North 14, West 5, Kita-Ku, Sapporo, Hokkaido, Japan
+81-11-716-1161
m-kato@med.hokudai.ac.jp
1st name | |
Middle name | |
Last name | Katsuhiro Mabe |
Hokkaido University Hospital
Division of Endoscopy
Kita14,Nishi5,Kita-ku,Sapporo
+81-11-716-1161
kmabe@med.hokudai.ac.jp
Hokkaido University Hospital, Division of Endoscopy
Hokkaido University Hospital, Division of Endoscopy
Self funding
NO
2014 | Year | 06 | Month | 26 | Day |
Unpublished
Completed
2014 | Year | 03 | Month | 17 | Day |
2014 | Year | 07 | Month | 01 | Day |
2014 | Year | 06 | Month | 26 | Day |
2016 | Year | 11 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015699